Molecular Targets of Tannic Acid in Alzheimer's Disease

被引:39
|
作者
Braidy, Nady [1 ,2 ]
Jugder, Bat-Erdene [2 ]
Poljak, Anne [1 ,3 ]
Jayasena, Tharusha [1 ]
Nabavi, Seyed Mohammad [4 ]
Sachdev, Perminder [1 ,5 ]
Grant, Ross [3 ,6 ,7 ]
机构
[1] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
[3] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia
[4] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, Tehran, Iran
[5] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia
[6] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia
[7] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Tannic acid; Alzheimer's disease; A beta pathology; tau; beta-secretase; neurons; AMYLOID PRECURSOR PROTEIN; MEMAPSIN-2; BETA-SECRETASE; DENDRITIC SPINE PATHOLOGY; GALLIC ACID; TAU-PROTEIN; COGNITIVE IMPAIRMENT; CEREBRAL-HEMORRHAGE; ACUTE TOXICITY; CELL BIOLOGY; HUMAN HEALTH;
D O I
10.2174/1567205014666170206163158
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tannic acid (TA) is a naturally occurring plant-derived polyphenol found in several herbaceous and woody plants, including legumes, sorghum, beans, bananas, persimmons, rasberries, wines and a broad selection of teas. Clinically, TA has strong antioxidant/free radical scavenging, antiinflammatory, anti-viral/bacterial, and anti-carcinogenic properties. While the aetiology of Alzheimer's disease (AD) remains unclear, this complex multifactorial neurodegenerative disorder remains the most common form of dementia, and is a growing public health concern worldwide. The neuroprotective effects of TA against AD have been shown in several in vitro and in vivo models of AD. Apart from its potent antioxidant and anti-inflammatory roles, evidence suggests that TA is also a natural inhibitor of beta-secretase (BACE1) activity and protein expression. BACE1 is the primary enzyme responsible for the production and deposition of A beta peptide. TA also destabilises neurotoxic amyloid beta (A beta) fibrils in vitro. Apart from its effects on the A beta cascade, TA can also inhibit the in vitro aggregation of tau peptide, a core component of intracellular neurofibrillary tangles (NFTs). This review summarizes the relevance of TA and TA-related vegetable extracts (tannins) in the pathogenesis of AD and its enzymatic targets. It also highlights the significance of TA as an important lead compound against AD.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 50 条
  • [21] Alzheimer's disease: immunity and diagnosis
    Herrera-Rivero, Marisol
    Elena Hernandez-Aguilar, Maria
    Manzo, Jorge
    Emiliano Aranda-Abreu, Gonzalo
    REVISTA DE NEUROLOGIA, 2010, 51 (03) : 153 - 164
  • [22] Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease
    Chavoshinezhad, Sara
    Beirami, Elmira
    Izadpanah, Esmael
    Feligioni, Marco
    Hassanzadeh, Kambiz
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [23] The Role of Neuroimmunomodulation in Alzheimer's Disease
    Maccioni, Ricardo B.
    Rojo, Leonel E.
    Fernandez, Jorge A.
    Kuljis, Rodrigo O.
    NEUROIMMUNOMODULATION: FROM FUNDAMENTAL BIOLOGY TO THERAPY, 2009, 1153 : 240 - 246
  • [24] Emerging Therapeutic Targets in Molecular Neuropharmacology for Alzheimer's Disease
    Bano, Sarika
    Raza, Muhammad Asim
    Ghosh, Shampa
    Pandit, Nayaab S.
    Srivastava, Saumya
    Azam, Mohammad
    Dey, Sanjay Kumar
    Han, Sung Soo
    Sinha, Jitendra Kumar
    Ruwali, Munindra
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (11) : 5769 - 5784
  • [25] Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics
    Cheng, Xuan
    Zhang, Lu
    Lian, Ya-Jun
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [26] Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
    Han, Sun-Ho
    Mook-Jung, Inhee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (07) : 893 - 902
  • [27] Molecular network of microRNA targets in Alzheimer's disease brains
    Satoh, Jun-ichi
    EXPERIMENTAL NEUROLOGY, 2012, 235 (02) : 436 - 446
  • [28] Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease
    Wang, Long
    Shui, Xindong
    Diao, Yuelin
    Chen, Duoting
    Zhou, Ying
    Lee, Tae Ho
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [29] Estrogen Signaling in Alzheimer's Disease: Molecular Insights and Therapeutic Targets for Alzheimer's Dementia
    Uddin, Md. Sahab
    Rahman, Md. Motiar
    Jakaria, Md.
    Rahman, Md. Sohanur
    Hossain, Md. Sarwar
    Islam, Ariful
    Ahmed, Muniruddin
    Mathew, Bijo
    Omar, Ulfat Mohammed
    Barreto, George E.
    Ashraf, Ghulam Md
    MOLECULAR NEUROBIOLOGY, 2020, 57 (06) : 2654 - 2670
  • [30] Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
    Hamze, Rim
    Delangre, Etienne
    Tolu, Stefania
    Moreau, Manon
    Janel, Nathalie
    Bailbe, Danielle
    Movassat, Jamileh
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)